Found: 7
Select item for more details and to access through your institution.
Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 1, doi. 10.3390/cancers13010001
- By:
- Publication type:
- Article
Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1599, doi. 10.1002/onco.13883
- By:
- Publication type:
- Article
Evaluación del miedo a la recurrencia del cáncer en español: el Cuestionario de Miedo a la Recurrencia del Cáncer y Escala General del Miedo a la Recurrencia del Cáncer: un estudio piloto.
- Published in:
- Psicooncologia, 2023, v. 20, n. 1, p. 155, doi. 10.5209/psic.87576
- By:
- Publication type:
- Article
Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti–PD‐L1, for BRCA wild‐type, platinum‐sensitive, recurrent ovarian cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 11, p. 1940, doi. 10.1002/cncr.35222
- By:
- Publication type:
- Article
Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 468, doi. 10.1007/s10637-018-0583-z
- By:
- Publication type:
- Article
Poly (ADP-Ribose) Polymerase Inhibitors in Ovarian Carcinoma.
- Published in:
- Cancer & Chemotherapy Reviews, 2015, v. 10, n. 3, p. 69
- By:
- Publication type:
- Article
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article